Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.53 |
| ▸ | BACE1 | P56817 | 7/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4204512 | 0.90 | HTT (0.55) | MEN1KMT2ARAB9ACNR1CNR2 | |
| SCHEMBL5226149 | 0.88 | MEN1 (0.55) | MEN1KMT2ARAB9ACNR1CNR2 | |
| SCHEMBL4186581 | 0.85 | CNR1 (0.62) | MEN1KMT2ARAB9ACNR1CNR2 | |
| SCHEMBL5223032 | 0.85 | CNR1 (0.60) | MEN1KMT2ARAB9ACNR1CNR2 | |
| SCHEMBL4192268 | 0.77 | CNR1 (0.58) | MEN1KMT2ARAB9ACNR1CNR2 | |
| SCHEMBL4194283 | 0.77 | CNR1 (0.62) | MEN1KMT2ARAB9ACNR1CNR2 | |
| SCHEMBL5258790 | 0.76 | HTT (0.70) | MEN1KMT2ARAB9ACNR1CNR2 | |
| SCHEMBL4191608 | 0.76 | CNR1 (0.59) | MEN1KMT2ARAB9ACNR1CNR2 | |
| SCHEMBL1308410 | 0.75 | GFER (0.76) | MEN1KMT2ARAB9ACNR1CNR2 | |
| SCHEMBL5261323 | 0.75 | HTT (0.62) | MEN1KMT2ACNR1CNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756044-A1 | THERAPEUTIC COMPOUNDS | AstraZeneca AB (SE) | 2007-02-28 | — | — | EP | claimed |
| WO-2005115972-A1 | THERAPEUTIC COMPOUNDS | ASTRAZENECA AB (SE) | 2005-12-08 | — | — | WO | claimed |
| EP-1756044-A1 | THERAPEUTIC COMPOUNDS | AstraZeneca AB (SE) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005115972-A1 | THERAPEUTIC COMPOUNDS | ASTRAZENECA AB (SE) | 2005-12-08 | — | — | WO | disclosed |